GET DAILY SIGNALSChurchill Capital Corp XI (CCXI) Falls -26% in 30 Days as SPAC Sentiment Cools
Key Takeaways
- Churchill Capital Corp XI (CCXI) fell roughly 26% over the last 30 days, declining from a closing price of $11.62 on September 30 to an intraday level around $8.63.
- The stock is trading below its $10.00 initial public offering reference price, reflecting weak sentiment in the blank-check/SPAC segment.
- CCXI is a special purpose acquisition company with no significant operations, so its valuation is driven by expectations around a future merger rather than earnings.
- The decline followed a speculative run-up earlier in the quarter, when shares briefly climbed above $18 intraday before reversing lower.
- With no announced business combination, the shares have been sensitive to broader risk appetite and SPAC-sector sentiment.
- Explore additional Price Targets, Earnings, and Forecast data on Tickeron's dedicated CCXI pages for deeper analysis.
- Discover how automated strategies are approaching this and other tickers by exploring Trending AI Robots.
Churchill Capital Corp XI (CCXI) and Its Role as a SPAC
CCXI is a special purpose acquisition company, or SPAC, incorporated in 2025 and based in New York. It has no meaningful operations and exists to complete a merger, share exchange, or similar transaction with one or more businesses. Michael Klein, a seasoned dealmaker, leads the company as founder, chairman, and CEO. The firm went public in December 2025 on Nasdaq, and investors track it mainly for the possibility of a future deal rather than any current financial performance. I also checked this using Tickeron’s AI Screener to see how the stock compares to others in the industry.
CCXI Stock Performance Over the Past 30 Days and Quarter
Over the last 30 days, CCXI dropped about 26%, moving from a September 30 close of $11.62 down to an intraday low near $8.63. That slide took the shares below the $10.00 IPO reference price. Looking back across the quarter, the picture shows even more volatility. The stock started near $14 in late July, pushed higher into mid-August with an intraday peak around $18.48, then reversed. From that early-quarter level to the recent area near $8.63, the decline reached roughly 38%, with the steepest part of the drop occurring in October after the break below $10.
Drivers Behind the 30-Day Slide in CCXI
The recent weakness stems from unwinding speculative positions and softer conditions across the SPAC space overall. Without an announced target or operating earnings to provide a valuation anchor, CCXI moves largely on sentiment about the odds of a future combination. After the August rally lost steam, the shares entered a steady downtrend. The decisive move below the $10 IPO level in October pointed to lower confidence that a deal would close on attractive terms. Broader risk-off market conditions and profit-taking after the earlier surge added pressure. From what I see, the absence of specific deal news has been the main factor.
Quarterly Price Action and the SPAC Cycle
Over the full quarter, CCXI followed a familiar pre-deal SPAC pattern. Speculative buying lifted the stock above $18 intraday in August, but the enthusiasm faded quickly once it became clear no definitive merger agreement was imminent. Without a fundamental event to support the higher valuation, the price gradually retraced toward and then below the trust reference level. The quarter essentially tells the story of a speculative peak followed by a prolonged re-rating of deal-completion odds.
Key Factors to Monitor for CCXI Going Forward
The single most important driver remains whether CCXI announces a business combination and on what terms. Investors should also keep an eye on broader SPAC market trends, redemption rates, and overall risk appetite. Regulatory updates affecting the sector and any management comments on timeline or target industry will matter as well. Macro conditions such as interest rates and equity volatility influence the financing environment for these transactions. I’m watching this closely through available data feeds.
Reviewing Automated Trading Strategies
I often turn to Tickeron’s AI Trading Bots when evaluating how systematic approaches are handling names like this one. The platform offers hundreds of AI-driven bots across thousands of tickers, and the Trending AI Robots section surfaces only the top-performing and most relevant ones at any given time. It lets me compare different styles, holding periods, and performance metrics in one place before deciding whether to explore further. For anyone following SPAC names, it provides a clear window into how rules-based systems are positioned right now.
Disclaimer
The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.
Contributor
Sergey Savastiouk, Ph.D. has a degree in Applied Mathematics from Moscow University and has extensive experience as an entrepreneur, investor, manager, and mathematician. His professional expertise is in applied mathematics, mathematical modeling, system and pattern analysis, and software and hardware system integration. He has served as the CEO of several hi-tech start-up companies and nonprofit organizations, which has given him proven capabilities in business strategy for high-tech start-up companies, market assessment, company formation, team building, product development, marketing, and sales. He has published numerous articles in journals and magazines on related fields. As a retail investor, he spent 15 years developing his proprietary trading and quantitative algorithms (now Tickeron’s A.I.), which brought him significant returns in trading the stock market. His current work and goal in founding Tickeron is to bring professional, sophisticated stock market analysis capabilities to retail investors via an easy-to-use interface.
CCXI's Stochastic Oscillator stays in oversold zone for 16 days
The price of this ticker is presumed to bounce back soon, since the longer the ticker stays in the oversold zone, the more promptly an uptrend is expected.
Technical Analysis (Indicators)
Bullish Trend Analysis
The RSI Indicator entered the oversold zone -- be on the watch for CCXI's price rising or consolidating in the future. That's also the time to consider buying the stock or exploring call options.
The Moving Average Convergence Divergence (MACD) for CCXI just turned positive on October 27, 2026. Looking at past instances where CCXI's MACD turned positive, the stock continued to rise in 6 of 9 cases over the following month. The odds of a continued upward trend are 67%.
Following a +3.87% 3-day Advance, the price is estimated to grow further. Considering data from situations where CCXI advanced for three days, in 58 of 83 cases, the price rose further within the following month. The odds of a continued upward trend are 70%.
Bearish Trend Analysis
The Momentum Indicator moved below the 0 level on September 30, 2026. You may want to consider selling the stock, shorting the stock, or exploring put options on CCXI as a result. In 11 of 24 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are 46%.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where CCXI declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 82%.
The Aroon Indicator for CCXI entered a downward trend on October 29, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.
Fundamental Analysis (Ratings)
The Tickeron PE Growth Rating for this company is 16 (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron Seasonality Score of 50 (best 1 - 100 worst) indicates that the company is fair valued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.
The Tickeron Price Growth Rating for this company is 63 (best 1 - 100 worst), indicating fairly steady price growth. CCXI’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron Valuation Rating of 96 (best 1 - 100 worst) indicates that the company is significantly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (2.064) is normal, around the industry mean (-540.337). P/E Ratio (-5.259) is within average values for comparable stocks, (117.314). Projected Growth (PEG Ratio) (2.600) is also within normal values, averaging (15.932). Dividend Yield (0.000) settles around the average of (0.020) among similar stocks. CCXI's P/S Ratio (0.000) is very low in comparison to the industry average of (3.158).
The Tickeron SMR rating for this company is 98 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron Profit vs. Risk Rating rating for this company is 100 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. CCXI’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 99, placing this stock worse than average.
Industry description
Market Cap
High and low price notable news
Volume
Fundamental Analysis Ratings
The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows
Advertisement
General Information
a developer and commercializer of small molecule therapeutics
Industry FinancialConglomerates
Advertisement